1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Brazil

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Brazil
BRAZIL 1
HEALTHCARE SYSTEM1
Facts and Figures1
Market Indicators2
Provision and Funding4
Healthcare System4
Decentralisation5
Healthcare Funding5
Healthcare Services5
Private Health Insurance6
PRICING 7
Prescription Drugs7
Pricing Procedure7
Drug Categories8
Application 9
Pricing Methodology10
Timelines11
Appeals11
Local Manufacturing Agreements 11
Generic Drugs12
Generics12
Similares13
Hospital Drugs13
Mandatory Discount13
Other Discounts14
Tendering14
OTC Drugs15
REIMBURSEMENT15
Admission to Reimbursement15
SUS Reimbursement Coverage16
RENAME17
Controversy 18
Popular Pharmacy Programme 19
Positive, Negative and Neutral Lists20
Private Health Plans 20
Reimbursement Categories21
Reimbursement Prices21
Hospital Reimbursement21
Formularies21
Funding22
Changes in Reimbursement Status23
Changes in Reimbursement Prices24
Annual Price Adjustment Limits 24
CAP Discounts25
PHARMACOECONOMICS 25
Pharmacoeconomic Requirements25
Pricing 25
Reimbursement 25
PRICE BUILD UP27
Wholesalers27
Margins27
Background28
Retail Pharmacies28
Margins28
Background29
Regulations29
Dispensing Doctors30
Sales Tax30
Recent Sales Tax Changes31
Recent Reform Proposals32
COST CONTAINMENT32
Industry Paybacks32
Promotional Costs32
Patient Co-payments33
Prescribing Controls33
National Therapeutic Formulary33
Protocols and Guidelines34
INN Prescribing 34
Hospital Sector34
Generics34
New Rules for Similares/Branded Copies35
Substitution35
Rx-to-OTC Switches36
OTC Sales36
Parallel Trade36
Counterfeit Trade36
FUTURE DEVELOPMENTS37
Outlook37
Healthcare Budget37
Popular Pharmacy Programme38
Sales Tax38
Orphan Drugs38
Medical Lawsuits39
NAMES and ADDRESSES40

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.